JUN 05, 2019 10:25 AM PDT

Anti-Diabetic Drug Reduces Anxiety-Like Symptoms

WRITTEN BY: Nouran Amin

In a study published in the Journal of Neuroscience, an antidiabetic drug called metformin was found to alleviate anxiety-like behavioral symptoms in male mice.

The paper ‘Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids’ found that beyond its clinical relevance in diabetes—metformin increased serotonin availability in the brain. It’s important to note that metformin is a medication often prescribed to treat high blood sugar by reducing glucose production in the liver and increasing insulin sensitivity.

The present study demonstrated that the insulin-sensitizing drug metformin administered to mice on a high fat diet has reduced the levels of amino acids that impair tryptophan entry into the brain. Tryptophan is a precursor molecule that is converted to serotonin.

The antidepressant-like effects of the medication was accompanied by an improved neurotransmission in the hippocampus. Similar effects were achieved upon the reduction of the so-called branched chained amino acids in the diet.

Individuals with diabetes are often prone to mood disorders most commonly depression. Despite the mechanisms underlying the relationship remain unknown, some studies suggest that the precursor to diabetes –insulin resistance and its connection to depression may be pinpointed to a strong culprit, the neurotransmitter serotonin.

The increase of serotonin along with the reduction in anxiety-like behaviors are findings that can implicate treatments for patients with both metabolic and mental disorders.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
APR 30, 2020
Drug Discovery & Development
APR 30, 2020
Shortcuts in Drug Development may Cause Long Term Damage
   
MAY 02, 2020
Cancer
MAY 02, 2020
Tracking DNA Methylation as a Prognostic Marker
In the modern age of biological research, one of the tools that have become readily available in the ever-increasing dat ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Does Herbal Drink from Madagascar Cure COVID-19?
Andry Rajoelina, the president of Madagascar, an island off the coast of Southern Africa, has made claims that his count ...
MAY 16, 2020
Cannabis Sciences
MAY 16, 2020
Body's Own Cannabis Helps Us Forget Traumatic Events
Researchers have found that anandamide, often referred to as the body’s own cannabis, may help us forget traumatic ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Novel Drug Approved for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) recently approved a therapeutic for treating metastatic non-small cell lung ca ...
Loading Comments...